Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients
Status:
RECRUITING
Trial end date:
2026-03-20
Target enrollment:
Participant gender:
Summary
A multi-center, prospective, randomized, double-blind, no-inferiority clinical trial designed to assess the the safety and efficacy of remazolam besylate in sedation of critically ill mechanically ventilated patients after surgery compared to dexmedetomidine.
Phase:
PHASE4
Details
Lead Sponsor:
Beijing Shijitan Hospital, Capital Medical University